Robert de Luccia
Net worth: 109 516 $ as of 2026-04-29
Net worth: 109 516 $ as of 2026-04-29
Mr. Robert J.
de Luccia is an Executive Chairman at Acurx Pharmaceuticals, Inc. and a Lead Independent Director at IBEX Technologies, Inc. He is on the Board of Directors at PLx Pharma, Inc. and IBEX Technologies, Inc. Mr. de Luccia was previously employed as an Executive Chairman by Dipexium Pharmaceuticals, Inc., a Chairman, President & Chief Executive Officer by MacroChem Corp., a President & Chief Executive Officer by Immunomedics, Inc., a Chief Executive Officer by Morris Plains Property LLC, a Vice President-Marketing & Sales Operations by Pfizer Inc., a President by Sanofi Winthrop, a President by Sanofi-Aventis U.S.
LLC, and a President by Sterling Winthrop, Inc. He also served on the board at Topigen Pharmaceuticals, Inc. He received his undergraduate degree from Iona College and an MBA from Iona College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-19 | 50,702 ( 3.2% ) | 109 516 $ | 2026-04-29 |
| Companies | Position | Start |
|---|---|---|
| IBEX TECHNOLOGIES | Director/Board Member | 1999-12-31 |
| ACURX PHARMACEUTICALS, INC. | Founder | 2017-06-30 |
| PLX PHARMA WINDDOWN CORP. | Director/Board Member | 2017-03-31 |
| Companies | Position | End |
|---|---|---|
Dipexium Pharmaceuticals, Inc.
Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Founder | 2017-03-31 |
MacroChem Corp.
MacroChem Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Chief Executive Officer | 2008-12-31 |
| IMMUNOMEDICS, INC. | Chief Executive Officer | 1998-12-31 |
Sanofi Winthrop
Sanofi Winthrop Pharmaceuticals: OtherHealth Technology Medicinal Chemicals And Botanical Products | President | - |
Morris Plains Property LLC
Morris Plains Property LLC Real Estate DevelopmentFinance Provides real estate services | Chief Executive Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 13 |
|---|---|
Immunomedics, Inc.
Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
MacroChem Corp.
MacroChem Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
IBEX Technologies, Inc.
IBEX Technologies, Inc. Pharmaceuticals: OtherHealth Technology Produces proprietary enzymes and reagents for diagnostic tests | Health Technology |
Dipexium Pharmaceuticals, Inc.
Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Sanofi Winthrop
Sanofi Winthrop Pharmaceuticals: OtherHealth Technology Medicinal Chemicals And Botanical Products | Health Technology |
Sterling Winthrop, Inc.
Sterling Winthrop, Inc. Electronics/AppliancesConsumer Durables Cameras; duplicating machines | Consumer Durables |
Iona College
Iona College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Topigen Pharmaceuticals, Inc.
Topigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for respiratory diseases | Health Technology |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Health Technology |
Morris Plains Property LLC
Morris Plains Property LLC Real Estate DevelopmentFinance Provides real estate services | Finance |
PLx Pharma, Inc.
PLx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops liquid-filled aspirin capsules for pain management | Health Technology |
Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company which develops antibiotics for infections caused by bacteria | Health Technology |
Select your edition
All financial news and data tailored to specific country editions